Tumour microenvironment and pituitary tumour behaviour

被引:0
|
作者
P. Marques
M. Korbonits
机构
[1] Hospital CUF Descobertas,Pituitary Tumor Unit, Endocrinology Department
[2] Universidade Católica Portuguesa,Faculdade de Medicina
[3] Queen Mary University of London,Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry
关键词
Pituitary tumour; Tumour microenvironment; Immune cell; Stromal cell; Fibroblast; Cytokine; Chemokine; Angiogenesis; Epithelial-to-mesenchymal transition; Immunotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
The pituitary tumour microenvironment encompasses a spectrum of non-tumoural cells, such as immune, stromal or endothelial cells, as well as enzymes and signalling peptides like cytokines, chemokines and growth factors, which surround the tumour cells and may influence pituitary tumour behaviour and tumourigenic mechanisms. Recently, there has been intensive research activity in this field describing various pituitary tumour-infiltrating immune and stromal cell subpopulations, and immune- and microenvironment-related pathways. Key changes in oncological therapeutic avenues resulted in the recognition of pituitary as a target of adverse events for patients treated with immune checkpoint regulators. However, these phenomena can be turned into therapeutic advantage in severe cases of pituitary tumours. Therefore, unravelling the pituitary tumour microenvironment will allow a better understanding of the biology and behaviour of pituitary tumours and may provide further developments in terms of diagnosis and management of patients with aggressively growing or recurrent pituitary tumours.
引用
收藏
页码:1047 / 1063
页数:16
相关论文
共 50 条
  • [31] Tumour immunity: effector response to tumour and role of the microenvironment
    Mantovani, Alberto
    Romero, Pedro
    Palucka, A. Karolina
    Marincola, Francesco M.
    [J]. LANCET, 2008, 371 (9614): : 771 - 783
  • [32] Mimicking the tumour microenvironment (TME): Angiogenesis in tumour progression
    Bonda, U. H.
    Bray, L. J.
    Lister, N.
    Ellem, S.
    Risbridger, G.
    Freudenberg, U.
    Werner, C. C.
    Hutmacher, D. W.
    De-Juan-Pardo, E. M.
    Loessner, D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : S62 - S62
  • [33] GLAUCOMA AND PITUITARY TUMOUR
    GODTFREDSEN, E
    [J]. ACTA OPHTHALMOLOGICA, 1968, 46 (03) : 600 - +
  • [34] PITUITARY FOSSA TUMOUR
    CADE, IS
    [J]. PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1955, 48 (09): : 759 - 760
  • [35] Pituitary tumour apoplexy
    Capatina, Cristina
    Inder, Warrick
    Karavitaki, Niki
    Wass, John A. H.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 172 (05) : R179 - R190
  • [36] Pituitary tumour pathogenesis
    Heaney, Anthony P.
    [J]. BRITISH MEDICAL BULLETIN, 2005, 75-76 : 81 - 97
  • [37] A case of pituitary tumour
    Elliott, CC
    Marais, DP
    [J]. BRITISH MEDICAL JOURNAL, 1931, 1931 : 297 - 299
  • [38] Interaction between intestinal microbiota and tumour immunity in the tumour microenvironment
    Yang, Xiuxiu
    Guo, Yaxin
    Chen, Chen
    Shao, Bo
    Zhao, Luyang
    Zhou, Quanbo
    Liu, Jinbo
    Wang, Guixian
    Yuan, Weitang
    Sun, Zhenqiang
    [J]. IMMUNOLOGY, 2021, 164 (03) : 476 - 493
  • [39] Tumour-associated macrophages: versatile players in the tumour microenvironment
    Ji, Zoey Zeyuan
    Chan, Max Kam-Kwan
    Chan, Alex Siu-Wing
    Leung, Kam-Tong
    Jiang, Xiaohua
    To, Ka-Fai
    Wu, Yi
    Tang, Patrick Ming-Kuen
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [40] Tumour endothelial cells acquire drug resistance in a tumour microenvironment
    Hida, Kyoko
    Akiyama, Kosuke
    Ohga, Noritaka
    Maishi, Nako
    Hida, Yasuhiro
    [J]. JOURNAL OF BIOCHEMISTRY, 2013, 153 (03): : 243 - 249